Government Patent Use to Promote Public Health in the United States

Overcoming Nonpatent Exclusivities

Bibliographic Data

ID11038541
AuthorsRebecca E Wolitz (Rebecca E. Wolitz is with the Moritz College of Law, The Ohio State University, Columbus. Jonathan J. Darrow and Aaron S. Kesselheim are with the Program on Regulation, Therapeutics, and Law, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA. Jonathan J. Darrow is also with the Department of Law & Taxation, Bentley University, Waltham, MA.), Aaron S Kesselheim (0000-0002-8867-2666, Rebecca E. Wolitz is with the Moritz College of Law, The Ohio State University, Columbus. Jonathan J. Darrow and Aaron S. Kesselheim are with the Program on Regulation, Therapeutics, and Law, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA. Jonathan J. Darrow is also with the Department of Law & Taxation, Bentley University, Waltham, MA.), Jonathan J Darrow (0000-0002-7351-4243, Rebecca E. Wolitz is with the Moritz College of Law, The Ohio State University, Columbus. Jonathan J. Darrow and Aaron S. Kesselheim are with the Program on Regulation, Therapeutics, and Law, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA. Jonathan J. Darrow is also with the Department of Law & Taxation, Bentley University, Waltham, MA.)
Year2022
Volume112
Issue8
Pages1110-1114
Publication date2022-08-01
Peer ReviewedYes
Open AccessNo
TypeARTICLE
VenueAmerican Journal of Public Health (JOURNAL)
Journal identifiersISSN: 0090-0036 • E-ISSN: 1541-0048
PublisherAmerican Public Health Association (PUBLISHER • US)
DOI10.2105/ajph.2022.306888
PMID35709409
OpenAlexW4283023162
LanguageEN
References cited4

Government Patent Use to Promote Public Health in the United States: Overcoming Nonpatent Exclusivities Rebecca E. WolitzJD, PhD, Aaron S. KesselheimMD, JD, MPH, and Jonathan J. DarrowSJD, LLM, JD, MBA Affiliation Rebecca E. Wolitz is with the Moritz College of Law, The Ohio State University, Columbus. Jonathan J. Darrow and Aaron S. Kesselheim are with the Program on Regulation, Therapeutics, and Law, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, MA. Jonathan J. Darrow is also with the Department of Law & Taxation, Bentley University, Waltham, MA. CopyRightCorrespondence should be sent to Jonathan J. Darrow, 1620 Tremont St, Suite 3030, Boston, MA 02120 (e-mail: [email protected]). Reprints can be ordered at http://www.ajph.org by clicking the “Reprints” link. CONTRIBUTORS All authors contributed to the conceptualization, design, writing, and revision of the editorial. https://doi.org/10.2105/AJPH.2022.306888 Accepted: April 07, 2022 Published Online: July 13, 2022

Family medicine · Government (linguistics) · Health care · Health department · International health · Local government · Political science · Public health · Public health law · State (computer science) · State government · Health Systems, Economic Evaluations, Quality of Life · Law · Medicine · Nursing · Pharmaceutical Economics and Policy · Pharmaceutical industry and healthcare · Public Administration · Gerontology · Health Policy

Tools

Open DOIOpen Access